Atika Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Atika Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-7,300	Closed	-$1.43M	–	101
2020 Q1	$1.43M	Sell	7,300 -2,200	-23%	-$473K	0.27%	77
2019 Q4	$1.96M	Sell	9,500 -2,500	-21%	-$462K	0.38%	63
2019 Q3	$1.83M	Sell	12,000 -7,000	-37%	-$1.15M	0.39%	61
2019 Q2	$2.45M	Hold	19,000	–	–	0.48%	68
2019 Q1	$2.24M	Sell	19,000 -10,200	-35%	-$1.03M	0.45%	65
2018 Q4	$2.68M	Sell	29,200 -35,900	-55%	-$3.64M	0.79%	49
2018 Q3	$7.32M	Buy	65,100 +6,100	+10%	+$644K	1.31%	24
2018 Q2	$5.44M	Buy	59,000 +41,000	+228%	+$3.98M	1.05%	34
2018 Q1	$1.8M	Buy	18,000 +2,500	+16%	+$269K	0.62%	58
2017 Q4	$1.45M	Sell	15,500 -30,500	-66%	-$2.89M	0.56%	58
2017 Q3	$4.68M	Buy	46,000 +28,000	+156%	+$2.45M	1.35%	16
2017 Q2	$1.38M	Sell	18,000 -7,800	-30%	-$656K	0.48%	63
2017 Q1	$2.22M	Buy	25,800 +2,800	+12%	+$202K	1.09%	44
2016 Q4	$1.48M	Sell	23,000 -29,000	-56%	-$1.78M	0.88%	45
2016 Q3	$3.36M	Buy	52,000 +31,000	+148%	+$1.75M	1.37%	24
2016 Q2	$1.17M	Buy	+21,000	New	+$1.06M	0.5%	51
2016 Q1	–	Sell	-42,000	Closed	-$2.64M	–	50
2015 Q4	$2.64M	Sell	42,000 -23,500	-36%	-$1.2M	1.36%	27
2015 Q3	$2.67M	Buy	65,500 +25,400	+63%	+$1.46M	1.31%	31
2015 Q2	$2.06M	Buy	+40,100	New	+$2.13M	0.93%	44

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Atika Capital Management's LKFT Position: Q2 2020 in Review

Atika Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2020, closing a stake of 7,300 shares — an estimated $1.43M sold.

Atika Capital Management first reported a position in LKFT in Q2 2015 and held it in 19 quarters. The position peaked at $7.32M in Q3 2018. 143 funds tracked by Wall St. Rank hold LKFT as of Q2 2020.

Atika Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2020 after selling out during the quarter.
Atika Capital Management sold 7,300 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2020, an estimated $1.43M.
Atika Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 19 quarters.
Atika Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $7.32M in Q3 2018.
143 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2020.

Based on Atika Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.